Know Cancer

or
forgot password

The miRNA Machinery in Melanoma, Melanoma Metastases and Benign Melanocytic Naevi


N/A
1 Year
N/A
Not Enrolling
Both
Cutaneous Melanoma, Nevi

Thank you

Trial Information

The miRNA Machinery in Melanoma, Melanoma Metastases and Benign Melanocytic Naevi


Patients with cutaneous melanoma, cutaneous melanoma metastases and benign melanocytic nevi
were included in the study. Punch biopsies were harvested from the center of the tumors. The
miRNA machinery components were detected by quantitative real-time reverse transcriptase
polymerase chain reaction.


Inclusion Criteria:



- cutaneous melanoma

- cutaneous melanoma metastases

- benign melanocytic nevi

Exclusion Criteria:

- other forms of malignancy

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Principal Investigator

Falk G Bechara, PD Dr.

Investigator Role:

Study Director

Investigator Affiliation:

Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum

Authority:

Germany: Ethics Commission

Study ID:

microRNA4

NCT ID:

NCT01444560

Start Date:

December 2008

Completion Date:

September 2011

Related Keywords:

  • Cutaneous Melanoma
  • Nevi
  • Melanoma
  • Skin Neoplasms
  • Neoplasm Metastasis
  • Nevus
  • Nevus, Pigmented
  • Nevus, Epithelioid and Spindle Cell

Name

Location